Medtronic €3 billion notes offering
The notes are due 2029, 2036, 2043 and 2053
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Elevance Health $2.6 billion senior notes offering
The investment-grade notes are due 2029, 2034 and 2054
Merck €3.4 billion notes offering
The investment-grade notes offering consists of four tranches
Perspective Therapeutics $80 million offering
The stock is listed on the NYSE American
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
Korro Bio $70 million private placement
The PIPE consists of common stock
TScan Therapeutics $150 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Market